Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia

Purinergic Signalling

Volumn 9, Issue 2, 2013, Pages 215-226

  Escudero, Carlos ^a   Bertoglia, Patricio ^a,b   Hernadez, Myriam ^a   Celis, Cristian ^a   Gonzalez, Marcelo ^c   Aguayo, Claudio ^c   Acurio, Jesenia ^a  

^a UNIVERSIDAD DEL BÍO BÍO   (Chile)

^b Obstetric and Gynecology Department   (Chile)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Adenosine; Adenosine receptor; Angiogenesis; Early and late onset preeclampsia; Nitric oxide; Placental

Indexed keywords

2 [4 (2 CARBOXYETHYL) PHENETHYLAMINO] ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1, 2, 4 TRIAZOLO [2, 3 A] [1, 3, 5] TRIAZIN 5 YLAMINO] ETHYL] PHENOL; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; N (G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG; VASCULOTROPIN; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; VASCULOTROPIN A;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; PREECLAMPSIA; PREMATURE LABOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL MOTION; DRUG EFFECTS; ENDOTHELIUM CELL; FETUS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; UMBILICAL VEIN; DRUG EFFECT;

ADENOSINE; BLOTTING, WESTERN; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; PURINERGIC P1 RECEPTOR AGONISTS; PURINERGIC P1 RECEPTOR ANTAGONISTS; RECEPTOR, ADENOSINE A2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877607150     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9341-4     Document Type: Article

References (48)

1. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365: 785-799.
2. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33: 130-137.
3. Roberts JM, Escudero C (2012) The placenta in preeclampsia. Pregnancy Hypertens 2: 72-83.
4. Di Paolo S, Volpe P, Grandaliano G, Stallone G, Schena A et al (2003) Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 16: 650-657.
5. Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30: 473-482.
6. Escudero C, Puebla C, Westermeier F, Sobrevia L (2009) Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia. Curr Vasc Pharmacol 7: 475-485.
7. Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M et al (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29: 407-413.
8. Geerts L, Odendaal HJ (2007) Severe early onset pre-eclampsia: prognostic value of ultrasound and Doppler assessment. J Perinatol 27: 335-342.
9. Meler E, Figueras F, Mula R, Crispi F, Benassar M et al (2010) Prognostic role of uterine artery Doppler in patients with preeclampsia. Fetal Diagn Ther 27: 8-13.
10. Roberts DJ, Post MD (2008) The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 61: 1254-1260.
11. Dahlstrom B, Romundstad P, Oian P, Vatten LJ, Eskild A (2008) Placenta weight in pre-eclampsia. Acta Obstet Gynecol Scand 87: 608-611.
12. Kajantie E, Thornburg KL, Eriksson JG, Osmond C, Barker DJ (2010) In preeclampsia, the placenta grows slowly along its minor axis. Int J Dev Biol 54: 469-473.
13. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD (2006) Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 113: 580-589.
14. Gellhaus A, Schmidt M, Dunk C, Lye SJ, Kimmig R et al (2006) Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod 12: 389-399.
15. Junus K, Centlow M, Wikstrom AK, Larsson I, Hansson SR et al (2012) Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease. Mol Hum Reprod 18: 146-155.
16. Espinoza J, Espinoza AF, Power GG (2011) High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol 205(485): e424-487.
17. Yoneyama Y, Sawa R, Suzuki S, Shin S, Power GG et al (1996) The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 174: 267-271.
18. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
19. Escudero C, Sobrevia L (2009) Understanding physiological significance of high extracellular adenosine levels in feto-placental circulation in preeclamptic pregnancies. In: Sobrevia L, Casanello P (eds) Membrane transporters and receptors in disease. Research Signpost, Kerala, India, pp 27-51.
20. Escudero C, Casanello P, Sobrevia L (2008) Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 29: 816-825.
21. George EM, Cockrell K, Adair TH, Granger JP (2010) Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol 299: R1629-1633.
22. Wen J, Grenz A, Zhang Y, Dai Y, Kellems RE et al (2011) A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation. FASEB J 25: 2823-2830.
23. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D et al (2002) Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16: 1584-1594.
24. Ansari HR, Nadeem A, Talukder MA, Sakhalkar S, Mustafa SJ (2007) Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta. Am J Physiol Heart Circ Physiol 292: H719-725.
25. Ray CJ, Marshall JM (2006) The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570: 85-96.
26. Casanello P, Torres A, Sanhueza F, Gonzalez M, Farias M et al (2005) Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res 97: 16-24.
27. Rey S, Del Rio R, Iturriaga R (2006) Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Brain Res 1086: 152-159.
28. Gruslin A, Lemyre B (2011) Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol 25: 491-507.
29. Karabulut AB, Kafkasli A, Burak F, Gozukara EM (2005) Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 23: 279-283.
30. Faas MM, van der Schaaf G, Borghuis T, Jongman RM, van Pampus MG et al (2010) Extracellular ATP induces albuminuria in pregnant rats. Nephrol Dial Transplant 25: 2468-2478.
31. von Versen-Hoynck F, Rajakumar A, Bainbridge SA, Gallaher MJ, Roberts JM et al (2009) Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta 30: 434-442.
32. Feoktistov I, Ryzhov S, Zhong H, Goldstein AE, Matafonov A et al (2004) Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44: 649-654.
33. Ryzhov S, McCaleb JL, Goldstein AE, Biaggioni I, Feoktistov I (2007) Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. J Pharmacol Exp Ther 320: 565-572.
34. Brown ST, Reyes EP, Nurse CA (2011) Chronic hypoxia upregulates adenosine 2a receptor expression in chromaffin cells via hypoxia inducible factor-2alpha: role in modulating secretion. Biochem Biophys Res Commun 412: 466-472.
35. Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM et al (2009) Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. PNAS 106: 10684-10689.
36. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A et al (2010) Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 5: e13288.
37. Olah ME, Stiles GL (2000) The role of receptor structure in determining adenosine receptor activity. Pharmacol Ther 85: 55-75.
38. Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I et al (2001) Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42: 2068-2073.
39. Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 279: H650-656.
40. Adair TH (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289: R283-R296.
41. Olanrewaju HA, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol 35: 171-177.
42. Taki A, Abe M, Komaki M, Oku K, Iseki S et al (2012) Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom 52: 97-103.
43. Bosco C, Gonzalez J, Gutierrez R, Parra-Cordero M, Barja P et al (2012) Oxidative damage to pre-eclamptic placenta: immunohistochemical expression of VEGF, nitrotyrosine residues and von Willebrand factor. J Matern Fetal Neonatal Med 25: 2339-2345. doi: 10. 3109/14767058. 2012. 695823.
44. Andraweera PH, Dekker GA, Laurence JA, Roberts CT (2012) Placental expression of VEGF family mRNA in adverse pregnancy outcomes. Placenta 33: 467-472.
45. Metaxa E, Meng H, Kaluvala SR, Szymanski MP, Paluch RA et al (2008) Nitric oxide-dependent stimulation of endothelial cell proliferation by sustained high flow. Am J Physiol Heart Circ Physiol 295: H736-742.
46. Heller R, Polack T, Grabner R, Till U (1999) Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis 144: 49-57.
47. Veas CJ, Aguilera VC, Munoz IJ, Gallardo VI, Miguel PL et al (2011) Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia. J Matern Fetal Neonatal Med 24: 1371-1377.
48. Riano A, Ortiz-Masia D, Velazquez M, Calatayud S, Esplugues JV et al (2011) Nitric oxide induces HIF-1alpha stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. J Gastroenterol 46: 565-576.